Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
Background: Clinical pharmacogenetics is a rapidly growing field that focuses on the study of genetic variations and their impact on drug metabolism, efficacy, and safety. Angiotensin II receptor blockers (ARBs) are commonly used to treat hypertension in Iraq but not all patients respond equally to...
Saved in:
Main Authors: | Hany A Al-Hussaniy (Author), Alaa F Hassan (Author), Amjad I Oraibi (Author), Atheer M R. Al-Juhaishi (Author), Fatima A Naji (Author), Zahraa S Al-Tameemi (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The relationship between statin therapy and adipocytokine/inflammatory mediators in dyslipidemic nondiabetic patients: A comparative study
by: Hany A. Al-hussaniy, et al.
Published: (2023) -
Angiotensin receptor blocker-neprilysin inhibitor for heart failure with reduced ejection fraction
by: Dima Nasrallah, et al.
Published: (2024) -
The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
by: Myla E. Moretti, et al.
Published: (2012) -
Current and future use of angiotensin II receptor blockers in patients with COVID-19
by: A. V. Matveev, et al.
Published: (2020) -
Onset of Hyperkalemia following the Administration of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker
by: Hye-Ran Jun, et al.
Published: (2021)